Journal home
Advance online publication
Current issue
Archive
Press releases
Free Association (blog)
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Biotechnology
Nature Cell Biology
Nature Medicine
Nature Methods
Nature Reviews Cancer
Nature Reviews Genetics
Nature Reviews Molecular Cell Biology
news@nature.com
Nature Conferences
Nature Reports Stem Cells
RNAi Gateway
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Letter
Nature Genetics 38, 479 - 483 (2006)
Published online: 19 March 2006; | doi:10.1038/ng1766

In vivo RNA interference demonstrates a role for Nramp1 in modifying susceptibility to type 1 diabetes

Stephan Kissler1, 5, Patrick Stern1, 5, Kazue Takahashi2, Kara Hunter3, Laurence B Peterson4 & Linda S Wicker3

1  Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.

2  Laboratory of Developmental Immunology, Massachusetts General Hospital for Children, Harvard Medical School, Boston, Massachusetts 02114, USA.

3  Diabetes and Inflammation Laboratory, Department of Medical Genetics, Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 2XY, UK.

4  Department of Pharmacology, Merck Research Laboratories, Rahway, New Jersey 07065, USA.

5  These authors contributed equally to this work.

Correspondence should be addressed to Stephan Kissler skissler@mit.edu

Type 1 diabetes is an autoimmune disease influenced by multiple genetic loci. Although more than 20 insulin-dependent diabetes (Idd) loci have been implicated in the nonobese diabetic (NOD) mouse model1, 2, few causal gene variants have been identified3, 4. Here we show that RNA interference5, 6 (RNAi) can be used to probe candidate genes in this disease model. Slc11a1 encodes a phagosomal ion transporter, Nramp1, that affects resistance to intracellular pathogens and influences antigen presentation7, 8, 9. This gene is the strongest candidate among the 42 genes in the Idd5.2 region; a naturally occurring mutation in the protective Idd5.2 haplotype results in loss of function of the Nramp1 protein10. Using lentiviral transgenesis11, we generated NOD mice in which Slc11a1 is silenced by RNAi. Silencing reduced the frequency of type 1 diabetes, mimicking the protective Idd5.2 region. Our results demonstrate a role for Slc11a1 in modifying susceptibility to type 1 diabetes and illustrate that RNAi can be used to study causal genes in a mammalian model organism.


 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend
rights and permissionsRights and permissions
Order commercial reprintsOrder commercial reprints
CrossRef lists 8 articles citing this articleCrossRef lists 8 articles citing this article
Save this linkSave this link
Figures & Tables
Supplementary info
Export citation

Open Innovation Challenges

naturejobs

natureproducts

Search buyers guide:

 
Nature Genetics
ISSN: 1061-4036
EISSN: 1546-1718
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2006 Nature Publishing Group | Privacy policy